Genesis announced that it has completed its second successful human transplant with a genetically engineered pig kidney, with ...

On Friday, doctors at Massachusetts General Hospital announced that a 66-year-old New Hampshire man had successfully received ...

The second person ever has received a transplant with a genetically modified pig kidney. Tim Andrews, a 66-year-old who lives in Concord, N.H., has end-stage kidney disease and had been on dialysis ...

The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics ...

United Therapeutics said the FDA has cleared it to begin the first clinical trial testing whether organs from gene-edited ...

It was the fourth pig kidney transplant in the United States, and the first of three that will be done at Mass General as part of a new clinical trial sanctioned by the Food and Drug Administration.

The U.S. Food and Drug Administration has approved the first-ever clinical trials testing pig kidney transplants in people ...

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...

For the second time in less than a year, doctors at Massachusetts General Hospital have transplanted a genetically-edited pig ...

The research offers hope to tens of thousands of patients with kidney failure who are on a long waiting list for an organ ...

Eledon Pharmaceuticals (ELDN) announced that tegoprubart, the company’s investigational anti-CD40L antibody, was used as a key component of the ...

A Massachusetts man suffering from end-stage kidney disease has become the second living person to receive a genetically modified pig kidney transplant, marking a major milestone in the field of ...